Clinical Trial Update: A Study to Evaluate Nivolumab in Japanese Participants With Muscle-invasive Urothelial Carcinoma

View source ↗

Summary

This clinical trial evaluates nivolumab in Japanese participants with muscle-invasive urothelial carcinoma. The study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Muscle-invasive Urothelial Carcinoma

Drugs mentioned

• OPDIVO (nivolumab)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Muscle-invasive Urothelial Carcinoma | Status: ACTIVE_NOT_RECRUITING